Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL249563 | 0.93 | DGKA (0.54) | DGKACYP19A1CA1CA12CA2 | |
| SCHEMBL14672499 | 0.93 | DGKA (0.48) | DGKACYP19A1CA1CA12CA2 | |
| SCHEMBL17581567 | 0.92 | DGKA (0.53) | DGKACYP19A1TDP1MAPTDNM1 | |
| SCHEMBL2396758 | 0.92 | DGKA (0.53) | DGKACYP19A1TDP1MAPTDNM1 | |
| SCHEMBL17581560 | 0.92 | DGKA (0.53) | DGKACYP19A1TDP1MAPTDNM1 | |
| SCHEMBL2397279 | 0.92 | DGKA (0.53) | DGKACYP19A1TDP1MAPTDNM1 | |
| SCHEMBL28449408 | 0.92 | DGKA (0.53) | DGKACYP19A1TDP1MAPTDNM1 | |
| SCHEMBL28449406 | 0.92 | DGKA (0.53) | DGKACYP19A1TDP1MAPTDNM1 | |
| SCHEMBL17581578 | 0.92 | DGKA (0.53) | DGKACYP19A1TDP1MAPTDNM1 | |
| SCHEMBL17581554 | 0.92 | DGKA (0.53) | DGKACYP19A1TDP1MAPTDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024017949-A1 | LIGNOCELLULOSIC BIOMASS REFINERY | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2024-01-25 | — | — | WO | disclosed |
| CN-111647975-A | Novel spandex oil agent and spandex obtained through treatment of novel spandex oil agent | 烟台锐泽化学品有限公司 | 2020-09-11 | — | — | CN | disclosed |
| CN-103772231-B | Compounds, its synthetic method and therepic use | GILEAD SCIENCES INC. (US) | 2016-02-03 | — | — | CN | disclosed |
| CN-102952033-A | Novel compound, composing method thereof and therapeutic use therefor | GILEAD SCIENCES INC (US) | 2013-03-06 | — | — | CN | disclosed |
| CN-101243096-B | Antiviral compounds | GILEAD SCIENCES INC | 2013-02-06 | — | — | CN | disclosed |
| CN-101172957-B | Novel compound, synthetic method thereof and therapeutic usage | GILEAD SCIENCES INC (US) | 2012-11-14 | — | — | CN | disclosed |
| CN-102532198-A | Antiviral phosphinate compounds | GILEAD SCIENCES INC | 2012-07-04 | — | — | CN | disclosed |
| CN-102216325-A | Method for purifying human growth hormone polypeptides using affinity resins comprising specific ligands | NOVO NORDISK AS | 2011-10-12 | — | — | CN | disclosed |
| US-20090224205-A1 | Odorant for hydrogen based on acrylate and amyl acetate | SYMRISE GMBH & CO. KG (DE) | 2009-09-10 | — | — | US | disclosed |
| CN-101489564-A | Antiviral phosphinate compounds | GILEAD SCIENCES INC (US) | 2009-07-22 | — | — | CN | disclosed |
| CN-1313472-C | Cellular Accumulation of Phosphonate Analogs of HIV Protease Inhibitor Compounds and Such Compounds | GILEAD SCIENCES INC (US) | 2007-05-02 | — | — | CN | disclosed |
| WO-2006067115-A1 | ODORANT FOR HYDROGEN BASED ON ACRYLATE AND AMYL ACETATE | SYMRISE GMBH & CO. KG (DE) | 2006-06-29 | — | — | WO | disclosed |
| CN-1733707-A | Compounds and methods for synthesis and therapy | GILEAD SCIENCES INC (US) | 2006-02-15 | — | — | CN | disclosed |
| CN-1656109-A | Non-nucleoside reverse transcriptase inhibitors | GILEAD SCIENCES INC (US) | 2005-08-17 | — | — | CN | disclosed |
| CN-1649885-A | Cellular Accumulation of Phosphonate Analogs of HIV Protease Inhibitor Compounds and Such Compounds | GILEAD SCIENCES INC (US) | 2005-08-03 | — | — | CN | disclosed |
| CN-1185223-C | Novel compounds, their synthesis and therapeutic use | GILEAD SCIENCES INC (US) | 2005-01-19 | — | — | CN | disclosed |
| CN-1347693-A | Novel compounds, their synthesis and therapeutic use | GILEAD SCIENCES INC (US) | 2002-05-08 | — | — | CN | disclosed |
| CN-1272105-A | Compound containing six-membered rings, processes for their preparation, and their use as medicaments | GILEAD SCIENCES INC (US) | 2000-11-01 | — | — | CN | disclosed |
| CN-1238762-A | Piperidine compounds | GILEAD SCIENCES INC (US) | 1999-12-15 | — | — | CN | disclosed |
| CN-1147813-A | Novel compounds, their synthesis and therapeutic use | GILEAD SCIENCES INC (US) | 1997-04-16 | — | — | CN | disclosed |